Literature DB >> 12141464

Evaluation of platelet and coagulation function in different animal species using the xylum clot signature analyzer.

Manabu Sato1, Hiroaki Harasaki.   

Abstract

Platelet and coagulation function were evaluated in four different animal species with a newly developed clot signature analyzer (CSA). CSA is unique in that it simultaneously measures global platelet and coagulation function under flow using whole blood. No anticoagulant, chemical, or immunologic agent is required. Three CSA parameters are measurable: platelet mediated hemostasis time (PHT), collagen induced thrombus formation time (CITF), and clotting time (CT). Bovine, ovine, and canine species were chosen because these are the animal models most frequently used in in vivo testing of cardiovascular implants. These parameters, as well as data from whole blood platelet aggregometry (commonly used for platelet function studies because of the response to exogenous agonists), and platelet counts from these animals, were measured and compared with those in humans. In all three parameters, the canine species showed distinctively shorter time values than other species, including humans, suggesting that the dog is not an ideal animal model for the evaluation of blood-surface interactions. Ovine and human blood showed similar PHT and CT values, but CITF time values were significantly shorter in sheep than in humans. With bovine blood, PHT was most prolonged among the four species compared. CT and CITF times in calves were shorter than those in humans, although the difference in CITF time was not statistically significant. Adenosine diphosphate induced platelet aggregation showed the same order of responsiveness in four species as did CITF. It was noted that the intermeasurement variation was rather high for CSA parameters, especially in PHT, warranting caution when this parameter is used to study time-dependent changes after device implantation.

Entities:  

Mesh:

Year:  2002        PMID: 12141464     DOI: 10.1097/00002480-200207000-00006

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  8 in total

Review 1.  Designer blood vessels and therapeutic revascularization.

Authors:  Joseph D Berglund; Zorina S Galis
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

2.  Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Authors:  M Preis; J Schneiderman; B Koren; Y Ben-Yosef; D Levin-Ashkenazi; S Shapiro; T Cohen; M Blich; M Israeli-Amit; Y Sarnatzki; D Gershtein; R Shofti; B S Lewis; Y Shaul; M Y Flugelman
Journal:  Gene Ther       Date:  2015-12-24       Impact factor: 5.250

3.  Platelet-rich plasma as a potential therapeutic approach against lead nitrate- and/or gamma radiation-induced hepatotoxicity.

Authors:  Salma M Abdel Fattah; Mostafa Saif-Elnasr; Ahmed F Soliman
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-11       Impact factor: 4.223

4.  Chronic in vivo testing of the Penn State infant ventricular assist device.

Authors:  William J Weiss; Elizabeth L Carney; J Brian Clark; Rebecca Peterson; Timothy K Cooper; Thomas P Nifong; Christopher A Siedlecki; Dennis Hicks; Bradley Doxtater; Branka Lukic; Eric Yeager; John Reibson; Joshua Cysyk; Gerson Rosenberg; William S Pierce
Journal:  ASAIO J       Date:  2012 Jan-Feb       Impact factor: 2.872

5.  Initial experience with a juvenile sheep model for evaluation of the pediatric intracorporeal ventricular assist devices [corrected].

Authors:  Xufeng Wei; Tieluo Li; Pablo G Sanchez; Pablo Sanchez; Amelia Watkins; Shuying Li; Christopher DeFilippi; Zhongjun J Wu; Bartley P Griffith
Journal:  ASAIO J       Date:  2013 Jan-Feb       Impact factor: 2.872

6.  Histological Reactions and the In Vivo Patency Rates of Small Silk Vascular Grafts in a Canine Model.

Authors:  Makoto Haga; Satoshi Yamamoto; Hiroyuki Okamoto; Katsuyuki Hoshina; Tetsuro Asakura; Toshiaki Watanabe
Journal:  Ann Vasc Dis       Date:  2017-06-25

Review 7.  Utilizing the Foreign Body Response to Grow Tissue Engineered Blood Vessels in Vivo.

Authors:  Wouter J Geelhoed; Lorenzo Moroni; Joris I Rotmans
Journal:  J Cardiovasc Transl Res       Date:  2017-02-15       Impact factor: 4.132

8.  Evaluation of small-diameter silk vascular grafts implanted in dogs.

Authors:  Takashi Tanaka; Ryo Tanaka; Yoko Ogawa; Yoshihide Takagi; Masataka Sata; Tetsuo Asakura
Journal:  JTCVS Open       Date:  2021-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.